CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 1.65: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.90BCNY281.89M · vs all stocks (USD)
Revenue (TTM)
864.90MCNY128.45M · vs all stocks (USD)
Profit Margin
-24.29%vs Medical Devices peers
Beta
0.1660xvs all stocks
52-Week Change
-53.91%vs all stocks
Market Capitalization
1.90BCNY281.89M · vs all stocks (USD)
Enterprise Value
1.91BCNY283.94M · vs all stocks (USD)
Forward P/E
3.36xvs Medical Devices peers
Price to Sales (TTM)
2.29xvs Medical Devices peers
Price to Book (MRQ)
1.28xvs Medical Devices peers
Enterprise to Revenue
2.21xvs Medical Devices peers
Enterprise to EBITDA
-9.48xvs Medical Devices peers
Gross Margin
45.95%vs Medical Devices peers
Profit Margin
-24.29%vs Medical Devices peers
Operating Margin
4.60%vs Medical Devices peers
Return on Assets (TTM)
-5.40%vs Medical Devices peers
Return on Equity (TTM)
-12.00%vs Medical Devices peers
Revenue (TTM)
864.90MCNY128.45M · vs all stocks (USD)
Revenue per Share (TTM)
3.17CNYUpdated Aug 19, 2026Quarterly Revenue Growth
37.10%vs Medical Devices peers
Gross Profit (TTM)
174.68MCNY25.94M · vs all stocks (USD)
EBITDA (TTM)
16.72MCNY2.48M · vs all stocks (USD)
Net Income (TTM)
-210.08MCNY-31.20M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
26.49%vs Medical Devices peers
Operating Cash Flow (TTM)
-66.32MCNY-9.85M · vs all stocks (USD)
5-Year Average Dividend Yield
2.31%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
4.07KCNYFY2025 · Dec 31, 2025Revenue
807.06MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
479.61MCNYFY2025 · Dec 31, 2025Gross Profit
327.45MCNYFY2025 · Dec 31, 2025Operating Income
-87.40MCNY-12.98M · vs all stocks (USD)
Pre-tax Income
-298.40MCNYFY2025 · Dec 31, 2025Income Tax Expense
-52.40MCNYFY2025 · Dec 31, 2025Net Income
-246.00MCNYFY2025 · Dec 31, 2025EBIT
-265.44MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
16.72MCNYFY2025 · Dec 31, 2025Research & Development
121.76MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
95.60MCNYFY2025 · Dec 31, 2025Other Operating Expenses
11.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
31.60MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
32.96MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.9000CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.9000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
273.32MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
273.32MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-246.00MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
9.06KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
35.57MCNYFY2025 · Dec 31, 2025Free Cash Flow
13.08MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
308.01MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-246.00MCNYFY2025 · Dec 31, 2025Other Non-cash Items
20.81MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
138.00MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
122.76MCNYFY2025 · Dec 31, 2025Capital Expenditures
-22.50MCNYFY2025 · Dec 31, 2025Purchase of Investments
-676.00MCNYFY2025 · Dec 31, 2025Sale of Investments
517.53MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-180.97MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
425.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-475.60MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-81.98MCNYFY2025 · Dec 31, 2025Other Financing Charges
-4.46MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-137.04MCNYFY2025 · Dec 31, 2025Shares Outstanding
272.70MSharesUpdated Aug 19, 2026Float Shares
130.26MSharesUpdated Aug 19, 2026% Held by Insiders
26.95%vs all stocks
% Held by Institutions
29.86%vs all stocks
Total Cash (MRQ)
536.51MCNY79.68M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.97CNYUpdated Aug 19, 2026Total Debt (MRQ)
471.22MCNY69.99M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3047xvs Medical Devices peers
Current Ratio (MRQ)
1.74xvs Medical Devices peers
Book Value per Share (MRQ)
5.67CNYUpdated Aug 19, 2026Total Assets
2.77BCNY411.71M · vs all stocks (USD)
Total Current Assets
1.72BCNYFY2025 · Dec 31, 2025Total Liabilities
1.24BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.05BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
280.96MCNYFY2025 · Dec 31, 2025Total Current Liabilities
954.27MCNYFY2025 · Dec 31, 2025Cash
308.01MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.58MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
309.59MCNYFY2025 · Dec 31, 2025Other Short-term Investments
180.32MCNYFY2025 · Dec 31, 2025Accounts Receivable
195.69MCNYFY2025 · Dec 31, 2025Inventory
568.01MCNYFY2025 · Dec 31, 2025Accounts Payable
167.25MCNYFY2025 · Dec 31, 2025Short-term Debt
205.70MCNYFY2025 · Dec 31, 2025Other Current Liabilities
49.79MCNYFY2025 · Dec 31, 2025Long-term Debt
245.30MCNYFY2025 · Dec 31, 2025Common Stock (Book)
272.70MCNYFY2025 · Dec 31, 2025Retained Earnings
844.90MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.54BCNY228.25M · vs all stocks (USD)
52-Week Low
5.96CNYUpdated Aug 19, 202652-Week High
15.25CNYUpdated Aug 19, 202652-Week Change
-53.91%vs all stocks
Beta
0.1660xvs all stocks
50-Day MA
6.70CNYUpdated Aug 19, 2026200-Day MA
10.77CNYUpdated Aug 19, 2026Avg 10-Day Volume
3.68MSharesUpdated Aug 19, 2026Avg 30-Day Volume
3.05MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.7700CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.46Profit Margin: -0.24
Financial Health
Altman Z-Score 1.65: grey zoneSignificant
Altman Z-Score: 1.65
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Alx Oncology Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Sichuan Gangtong Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Cresco Labs Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Shanghai Hile Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Lineage Cell Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Inventage Lab Inc.
Tier 1ProductionApproval-Gated PipelineRule
Curocell Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Oryzon Genomics S.A.
Tier 1ProductionApproval-Gated PipelineRuleRisk
CytoDyn Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Cutia Therapeutics Limited
Tier 1ProductionApproval-Gated PipelineRuleRisk